Pages that link to "Q28201908"
Jump to navigation
Jump to search
The following pages link to Peptide and protein PEGylation: a review of problems and solutions (Q28201908):
Displaying 50 items.
- PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilities (Q24594884) (← links)
- Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein (Q24814238) (← links)
- Automated solid-phase peptide synthesis to obtain therapeutic peptides (Q27001623) (← links)
- (Q28160667) (redirect page) (← links)
- Introduction and overview of peptide and protein pegylation (Q28203070) (← links)
- Advances in PEGylation of important biotech molecules: delivery aspects (Q28277255) (← links)
- sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo (Q28552652) (← links)
- Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase (Q28727969) (← links)
- (Q29037464) (redirect page) (← links)
- Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. (Q30366990) (← links)
- Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design. (Q30383551) (← links)
- Interactions of oligomers of organic polyethers with histidine amino acid. (Q30412514) (← links)
- Polyethylene glycol-conjugated adenosine phosphorylase: development of alternative enzyme therapy for adenosine deaminase deficiency (Q30768574) (← links)
- An improved procedure for the synthesis of branched polyethylene glycols (PEGs) with the reporter dipeptide Met-betaAla for protein conjugation. (Q30783887) (← links)
- Synthesis of poly(ethylene glycol) with sulfadiazine and chlorambucil end groups and investigation of its antitumor activity (Q30810973) (← links)
- Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity (Q30838211) (← links)
- A brain-sparing diphtheria toxin for chemical genetic ablation of peripheral cell lineages. (Q30844300) (← links)
- Synthesis and facile end-group quantification of functionalized PEG azides (Q31142167) (← links)
- Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification (Q33203656) (← links)
- Tailoring structure-function properties of L-asparaginase: engineering resistance to trypsin cleavage (Q33274867) (← links)
- Toward top-down determination of PEGylation site using MALDI in-source decay MS analysis (Q33385574) (← links)
- Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels. (Q33399982) (← links)
- Emerging PEGylated drugs (Q33447691) (← links)
- PEGylation of interleukin-10 for the mitigation of enhanced pain states (Q33505369) (← links)
- Phosphorylcholine-based stealthy nanocapsules enabling tumor microenvironment-responsive doxorubicin release for tumor suppression (Q33588194) (← links)
- PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity (Q33665491) (← links)
- Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations (Q33689742) (← links)
- Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity (Q33763719) (← links)
- Evaluation of in vitro cytotoxic activity of mono-PEGylated StAP3 (Solanum tuberosum aspartic protease 3) forms. (Q33783104) (← links)
- Targeting microspheres and cells to polyethylene glycol-modified biological surfaces (Q33862257) (← links)
- Designing and engineering of a site-specific incorporation of a keto group in uricase. (Q33902703) (← links)
- Density contrast sedimentation velocity for the determination of protein partial-specific volumes (Q34058464) (← links)
- A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation (Q34165587) (← links)
- Tumour therapy with radionuclides: assessment of progress and problems. (Q34185077) (← links)
- Polymeric materials for advanced drug delivery. (Q34456719) (← links)
- Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. (Q34489836) (← links)
- Anti-amyloid-β-mediated positron emission tomography imaging in Alzheimer's disease mouse brains (Q34532633) (← links)
- Sortase-catalyzed transformations that improve the properties of cytokines (Q34602642) (← links)
- Chemistry for peptide and protein PEGylation (Q34674747) (← links)
- Poly(ethylene glycol) block copolymers. (Q34690033) (← links)
- Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy (Q34766341) (← links)
- Pegylation: engineering improved pharmaceuticals for enhanced therapy (Q34782103) (← links)
- In vivo anti-tumor activity of polypeptide HM-3 modified by different polyethylene glycols (PEG). (Q35079289) (← links)
- Pegylation: engineering improved biopharmaceuticals for oncology (Q35200818) (← links)
- Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy (Q35200824) (← links)
- The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin. (Q35208747) (← links)
- Tunable degradation of maleimide-thiol adducts in reducing environments (Q35562329) (← links)
- Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells (Q35605763) (← links)
- The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes (Q35669424) (← links)
- Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha. (Q35805537) (← links)